ACR Ann: Acrux's seventh generic dossier accepted by FDA for review - 4th Jul 2023, 8:38am

annb0t

annb0t

Top 20
ACR Ann: Acrux's seventh generic dossier accepted by FDA for review
Price Sensitive: Y
Date: 4th Jul 2023, 8:38am

>>> Read announcement: Google: ACR Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
ACR Ann: Acrux and Dash mutually terminate commercial agreement - 19th Sep 2023, 9:16am
Replies
0
Views
94
annb0t
annb0t
annb0t
ACR Ann: Investor Presentation - Acrux FY23 Results - 25th Aug 2023, 8:27am
Replies
0
Views
64
annb0t
annb0t
annb0t
ACR Ann: Acrux's sixth generic dossier accepted by FDA for review - 8th Aug 2022, 9:33am
Replies
0
Views
206
annb0t
annb0t
annb0t
ACR Ann: Acrux announces commercial agreement with Padagis - 20th Jun 2022, 9:51am
Replies
0
Views
217
annb0t
annb0t
annb0t
ACR Ann: Notice of Annual General Meeting/Proxy Form - 27th Oct 2023, 9:04am
Replies
0
Views
85
annb0t
annb0t
Top Bottom